Phosphorylation of RGS16 at Tyr168 promote HBeAg-mediated macrophage activation by ERK pathway to accelerate liver injury

Abstract Liver injury is closely associated with macrophage activation following HBV infection. Our previous study showed that only HBeAg, but not HBsAg and HBcAg, stably enhances inflammatory cytokine production in macrophages. And we also indicated that HBeAg could induce macrophage activation via TLR2 and thus aggravate the progression of liver fibrosis. However, the specific molecular mechanism of HBeAg in macrophage activation is not clear. We screened significantly overexpressed RGS16 from RNASeq results of HBeAg-stimulated macrophages and validated them with cellular assays, GSE83148 microarray dataset, and in clinical samples. Meanwhile, small interference, plasmid, and lentivirus transfection assays were used to establish cell models for knockdown and overexpression of RGS16, and q-PCR, ELISA, Transwell, and CCK-8 assays were used to analyze the role of RGS16 in HBeAg-induced macrophage activation. In addition, the upstream and downstream mechanisms of RGS16 in HBeAg-treated macrophage activation were explored using inhibitors, phostag gels, and RGS16 phosphorylation mutant plasmids. Finally, the effect of RGS16 on hepatic inflammation in murine tissues was evaluated by H&E staining, liver enzyme assay and immunofluorescence. RGS16 was significantly upregulated in HBeAg-induced macrophage activation, and its expression was enhanced with increasing HBeAg content and treatment time. Functional experiments showed that overexpression of RGS16 promoted the production of inflammatory factors TNF-α and IL-6 and boosted macrophage proliferation and migration, while knockdown of RGS16 exhibited the opposite effect. Mechanistically, we discovered that RGS16 is regulated by the TLR2/P38/STAT5 signaling pathway. Meanwhile, RGS16 enhanced ERK phosphorylation via its own Tyr168 phosphorylation to contribute to macrophage activation, thereby accelerating liver injury. Finally, in mice, overexpression of RGS16 markedly strengthened liver inflammation. HBeAg upregulates RGS16 expression through the TLR2-P38-STAT5 axis, and the upregulated expression of RGS16 enhances macrophage activation and accelerates liver injury by promoting ERK phosphorylation. In this process, phosphorylation of Tyr168 is necessary for RGS16 to function. Key messages RGS16 boosted HBeAg-induced macrophage inflammation, proliferation, and migration.Tyr168 phosphorylation of RGS16 affected by ERK promoted macrophage activation.HBeAg upregulated the expression of RGS16 through TLR2/P38/STAT5 signal pathway.RGS16 promoted liver injury by regulating macrophage functions in mouse model..

Medienart:	E-Artikel

Erscheinungsjahr:	2023
Erschienen:	2023

Enthalten in:	Zur Gesamtaufnahme - volume:102
Enthalten in:	Journal of molecular medicine - 102(2023), 2 vom: 23. Dez., Seite 257-272

Sprache:	Englisch

Beteiligte Personen:	Tian, Miaomiao [VerfasserIn] Wu, Nijin [VerfasserIn] Xie, Xiaoyu [VerfasserIn] Liu, Tiantian [VerfasserIn] You, Yajing [VerfasserIn] Ma, Shujun [VerfasserIn] Bian, Hongjun [VerfasserIn] Cao, Huiling [VerfasserIn] Wang, Le [VerfasserIn] Liu, Chenxi [VerfasserIn] Qi, Jianni [VerfasserIn]

Links:	Volltext [lizenzpflichtig]

Themen:	HBeAg Liver injury Macrophage Phosphorylation RGS16

Anmerkungen:

© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

doi:	10.1007/s00109-023-02405-5

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	SPR054702631